|Bid||0.9400 x 0|
|Ask||0.9700 x 0|
|Day's Range||0.9300 - 0.9900|
|52 Week Range||0.2700 - 1.1500|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar. 08, 2016|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - March 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE:TBF1) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its 2nd (second) delivery of (2) (two) additional SKU's ordered by MediPharm Labs Corp ("MediPharm Labs") (TSX: LABS) (OTCQX: MEDIF) including 12.5mg CBD caplets (hard tablets in the shape ...
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engaged Independent Trading Group Inc. ("ITG") to provide market-making services to the Company. ITG will trade the Company's common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE") and other marketplaces, ...
10, 2021 /CNW/ -- AirConsole launches a hot new quiz for couples that are caught in lockdown for Valentine's Day 2021 due to the ongoing pandemic. This year, you will truly get to know your partner.